This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody & ADC Summit At ChinaBio
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026

Jerome Boyd-Kirkup, PhD
Chief Scientific Officer and Co-Founder at Callio Therapeutics
Speaker

Profile

Jerome is Chief Scientific Officer and Co-founder of Callio Therapeutics where he oversees research and early development. Prior to co-founding Callio Therapeutics, Jerome co-founded Hummingbird Bioscience. Jerome’s career has focused on tackling human disease by applying systems biology approaches. A molecular biologist by background with extensive experience in computational and wet lab biology, Jerome holds a Bachelor’s and Master’s degree in Biochemistry from Imperial College London and a PhD in Molecular Biology from Cambridge University.

Agenda Sessions

  • Harnessing the Therapeutic Promise of Multi-payload ADCs

    15:45